Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 September 2019

Abstract and Keywords

Access to medicines has been a fierce battleground in global health, with the most polarising debates focused on medicine prices and the role of patent monopolies. The way ‘access to medicines’ has been framed has evolved considerably since the 1970s, when the focus was primarily on rational use of generic drugs widely available in developing countries. In the 1990s the advent of the WTO TRIPS Agreement clashed directly with a growing global HIV crisis; the politics of ‘access to medicines 1.0’ that emerged centred squarely on antiretrovirals for HIV/AIDS and intellectual property rules. Subsequently, significant ideational and political shifts have resulted in an ‘access politics 2.0,’ characterised by an expansion of concerns to all diseases, tighter linkages between innovation and access concerns, and shifting political dynamics as high-income countries began to experience directly the challenge of high drug prices. These shifts imply a more complex and potentially more consequential politics of access to medicines in the future.

Keywords: access to medicines, pharmaceuticals, innovation, research and development,, intellectual property, patents, WTO TRIPS, HIV/AIDS, North-South, developing countries

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.